EMEA-000924-PIP01-10
Submitted by Anonymous (not verified) on 23 June 2026 - 16:20
EMEA-000924-PIP01-10
EMEA-000923-PIP02-10
Submitted by Anonymous (not verified) on 23 June 2026 - 16:15
EMEA-000923-PIP02-10
EMEA-000922-PIP02-10
Submitted by Anonymous (not verified) on 23 June 2026 - 16:11
EMEA-000922-PIP02-10
Human medicines European public assessment report (EPAR): Ikervis, ciclosporin, Date of authorisation: 19/03/2015, Revision: 12, Status: Authorised
Submitted by Anonymous (not verified) on 23 June 2026 - 16:10
Human medicines European public assessment report (EPAR): Ikervis, ciclosporin, Date of authorisation: 19/03/2015, Revision: 12, Status: Authorised
EMEA-000921-PIP01-10
Submitted by Anonymous (not verified) on 23 June 2026 - 16:07
EMEA-000921-PIP01-10
EMEA-000918-PIP01-10
Submitted by Anonymous (not verified) on 23 June 2026 - 16:02
EMEA-000918-PIP01-10
Agenda - PDCO agenda of the 23-26 June 2026 meeting
Submitted by Anonymous (not verified) on 23 June 2026 - 16:00
Agenda - PDCO agenda of the 23-26 June 2026 meeting
EMEA-000919-PIP01-10
Submitted by Anonymous (not verified) on 23 June 2026 - 15:56
EMEA-000919-PIP01-10
Human medicines European public assessment report (EPAR): Pomalidomide Accord, pomalidomide, Date of authorisation: 26/07/2024, Revision: 1, Status: Authorised
Submitted by Anonymous (not verified) on 23 June 2026 - 15:55
Human medicines European public assessment report (EPAR): Pomalidomide Accord, pomalidomide, Date of authorisation: 26/07/2024, Revision: 1, Status: Authorised
EMEA-000926-PIP01-10
Submitted by Anonymous (not verified) on 23 June 2026 - 15:35
EMEA-000926-PIP01-10